Global $223.21 Billion Oncology Drugs Markets to 2031 with F.Hoffmann-La Roche, Novartis, Gilead Sciences, Bayer and Takeda Pharmacueticals Dominating
June 21, 2022 07:13 ET | Research and Markets
Dublin, June 21, 2022 (GLOBE NEWSWIRE) -- The "Oncology Drugs Global Market Report 2022, By Type, Drug Type, Drug Classification" report has been added to ResearchAndMarkets.com's offering. The...
Four Independent Studies of Voraxaze® Published at European Hematology Conference 2022
June 09, 2022 04:49 ET | BTG Specialty Pharmaceuticals
Vienna, June 09, 2022 (GLOBE NEWSWIRE) -- The European Hematology Association (EHA) Conference published four independent studies of Voraxaze® (glucarpidase) by various investigators for inclusion...
22157.jpg
Global PARP Inhibitors Cancer Therapy Market Outlook 2022-2028: PARP Inhibitors have Proved to be a Commercial Success in the Modern Cancer Therapeutic Segment
June 08, 2022 04:43 ET | Research and Markets
Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Global PARP Inhibitors Cancer Therapy Market, Price, Dosage & Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's...
Sm-logo-resized.jpg.png
Metastatic Breast Cancer Treatment Market worth $41.74 Billion by 2030, Registering a CAGR of 10.4%
June 06, 2022 10:40 ET | STRATEGIC MARKET RESEARCH LLP
New York, United States, June 06, 2022 (GLOBE NEWSWIRE) -- Metastatic breast cancer is another word for the advanced form of breast cancer. Breast cancer is a kind of disease in which the breast...
Straits Research Pvt Ltd
Ovarian Cancer Market to reach a market size of USD 19.92 Billion by 2030 growing at a CAGR of 23.8%: Straits Research
May 30, 2022 12:50 ET | Straits Research
New York, United States, May 30, 2022 (GLOBE NEWSWIRE) -- Ovarian cancer drugs are sold to treat ovarian cancer in the Ovarian Cancer Market. The leading cause of ovarian cancer is abnormal cell...
TIP_link_300x300.jpg
CIPN Market: 5.4% CAGR for Chemotherapy-Induced Peripheral Neuropathy Market Worth $1.17 Billion, Globally, by 2028: The Insight Partners
May 26, 2022 15:07 ET | The Insight Partners
New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Chemotherapy-Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global...
22157.jpg
Global Head and Neck Cancer Therapeutics Market Report 2022: Historical Data 2017-2020, Base year of 2021, Estimates for 2022, & Forecasts 2023-2027
May 20, 2022 04:38 ET | Research and Markets
Dublin, May 20, 2022 (GLOBE NEWSWIRE) -- The "Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods v/s Treatment Type), By Treatment Type (By Disease Indication, By Route of...
Global Cancer Cachexia Market Report 2022: Market to Reach $2.9 Billion by 2027 - North America and Europe Constitute Major Regions, Asia-Pacific Exhibits the Fastest Growth
May 13, 2022 08:13 ET | Research and Markets
Dublin, May 13, 2022 (GLOBE NEWSWIRE) -- The "Cancer Cachexia - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Cancer Cachexia Market to...
new_logo.png
Oncology Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
May 12, 2022 08:00 ET | Graphical Research
Pune, India, May 12, 2022 (GLOBE NEWSWIRE) -- The global oncology market size is anticipated to rise substantially through 2028, attributed to the rising incidence of cancer across many regions...
22157.jpg
United Kingdom Private Healthcare Self-Pay Market Report 2022: Impact of Covid-19 & Reasons for Self-pay Market Growth
May 11, 2022 05:48 ET | Research and Markets
Dublin, May 11, 2022 (GLOBE NEWSWIRE) -- The "Private Healthcare Self-Pay UK Market Report: Fourth Edition" report has been added to ResearchAndMarkets.com's offering. This report delivers...